As more drug targets are discovered in the fight to treat diseases such as cancer, producing the right drugs for these targets is key to providing the best treatment and prolonging health in cancer patients.READ MORE
Could therapies targeting our immune system help treat Alzheimer's disease by flipping long-standing research theories on their head? A new drug targeting a two-faced protein is currently undergoing clinical trials to find an answer.READ MORE
In this interview, conducted at the Neuroscience 2019 conference, we talk with DeepLabCut’s co-creator, Dr Mackenzie Mathis, a principal investigator at Harvard’s Rowland Institute, about open science, DeepLabCut’s potential for prosthetics, and how to safeguard against automated software being used for the wrong reasons.
In this article, we will take an in-depth look at fibromyalgia: what it is, what causes it, and how researchers recommend finding relief.
What do we mean by lab of the future? What innovations are required to get there? These are the key themes explored by this year's Lab of the Future Congress, summarized in this article.READ MORE
The US Food and Drug Administration (FDA) guidance on data integrity has challenged firms to "implement meaningful and effective strategies to manage their data integrity risks" to maintain integrity. In this article, BioData's Steve Yemm explains how Electronic Lab Notebooks (ELNs) help to meet these standards.READ MORE
If the rapid migration of deadly fentanyls wasn’t difficult to keep up with already, they are also evading analysts through their chemistry. Due to an inexpensive and flexible production process, unique versions of the synthetic opioids are regularly cooked up by illicit chemists, creating new dangers for consumers and new headaches for toxicologists.READ MORE
Climate change has emerged as the biggest threat to humanity. How can technologies like AI and machine learning lend a hand? Let’s examine the three main benefits that ML and its derivatives can offer to the organizations fighting for the future of our planet.
Effective treatments for post-traumatic stress disorder (PTSD) have proved extremely elusive to researchers. For some, the legalisation of cannabis could present an opportunity to develop new therapies for PTSD.We talked to Allied Corp’s CEO Calum Hughes about cannabis’s potential for PTSD therapeutics.